Michael Alfieri
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Alfieri
Michael Alfieri is recorded as CFO at Aldeyra Therapeutics, Inc. (ALDX). Aldeyra Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Michael Alfieri was appointed principal financial officer and principal accounting officer, effective August 31, 2024. The proxy statement of Aldeyra Therapeutics, Inc. reports total compensation of $245,963 for Michael Alfieri in fiscal 2025. Disclosed compensation is on record for 2 fiscal years.
“On August 29, 2024, the board of directors of Aldeyra Therapeutics, Inc. (the "Company") approved the appointment of Michael Alfieri as the Company's principal financial officer and principal accounting officer effective as of August 31, 2024 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-31–present
-
Aldeyra Therapeutics, Inc. (ALDX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aldeyra Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gary M. Phillips CEO, Board Member
- Neal S. Walker CEO
- Todd C. Brady CEO, Board Member
- William D. Clark CEO, Board Member
- Martin J. Joyce CFO, Board Member
- Darlene Deptula-Hicks Board Member
- Nancy B. Miller-Rich Board Member
- William (Chip) Clark Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Principal Financial Officer and Principal Accounting Officer | — | $245,963 |
| 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Principal Financial Officer and Principal Accounting Officer | — | $111,650 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.